Skip to main content
[Preprint]. 2023 Mar 2:2023.02.28.23286515. [Version 1] doi: 10.1101/2023.02.28.23286515

Table III.

Ventilation outcomes in patient subgroups

Subgroup No. of
pairs
Endpoint in
treatment
Endpoint in
control
PSM LR
OR (CI) p OR (CI) p
15-59 4,106 350 (8.5%) 435 (10.6%) 0.78 (0.67-0.91) 0.002 0.73 (0.65-0.82) <0.001
60-74 6,813 656 (9.6%) 803 (11.8%) 0.80 (0.71-0.89) <0.001 0.79 (0.73-0.87) <0.001
75- 5,405 206 (3.8%) 253 (4.7%) 0.81 (0.67-0.97) 0.028 0.75 (0.65-0.87) <0.001
Male 7,141 583 (8.2%) 750 (10.5%) 0.76 (0.67-0.85) <0.001 0.72 (0.66-0.79) <0.001
Female 9,183 629 (6.8%) 718 (7.8%) 0.87 (0.77-0.97) 0.012 0.84 (0.77-0.92) <0.001
BMI ≥30 3,486 447 (12.8%) 474 (13.6%) 0.93 (0.81-1.07) 0.352 0.89 (0.80-0.99) 0.026
BMI <30 12,838 765 (6.0%) 933 (7.3%) 0.81 (0.73-0.89) <0.001 0.74 (0.69-0.80) <0.001
Delta wave 3,881 355 (9.1%) 408 (10.5%) 0.85 (0.73-0.99) 0.044 0.76 (0.68-0.86) <0.001
Omicron wave 3,329 203 (6.1%) 222 (6.7%) 0.91 (0.74-1.11) 0.37 0.80 (0.69-0.93) 0.004